NewGenIvf Group Limited (Class A) (NIVF) Dividend Safety Gauge & 10-Year DRIP Compounder

NIVF carries an RQD Score of 20, a letter grade of E, and the verdict label "Roarable Strong Sell — Forensic Risk / Avoid." Across the five pillars, the Fundamental Cash Engine scores 1/20 (ROIC -32.8%; FCF yield 0%), indicating the weakest element of the rating: the business is not currently generating a return on invested capital or free cash flow relative to its price. The Whale 13F Flow pillar scores 3/20 for institutional accumulation and options positioning, and Insider Conviction scores 5/20 for SEC Form 4 and Congressional PTR cluster flow, both signaling limited sponsorship from informed holders. Macro Regime Fit scores 7/20 with a Beta of 1.0 and sector sensitivity noted, offering little macro tailwind. The Forensic Balance Sheet pillar scores 4/20 (Altman Z 0.63; Piotroski F 3/9; Debt/Equity 0.5), which places the company in a distress-leaning zone on the forensic metrics provided.

NewGenIvf Group Limited (Class A) (NIVF) is a NASDAQ-listed operating company in the Misc Health and Biotechnology Services industry (Health Care sector) with an equity market capitalization of $9.7M. The business operates with a gross margin of 0%, an operating margin of -60%, and a return on invested capital (ROIC) of -32.8% (free cash flow yield of 0%). Within the Misc Health and Biotechnology Services peer group, investor evaluation centers on operating leverage, unit margin durability, and capital allocation efficiency across market cycles.

Per the market data, operating margin is -60%, gross margin is 0%, and net margin is 68%, with the net margin figure diverging sharply from the operating loss reported for FY 2025. ROIC is -32.8% and FCF yield is 0%. The Altman Z-Score is 0.63 and the Piotroski F-Score is 3/9, with Debt/Equity at 0. — for EPS across the reported periods.

• 🐂 Primary Bull Case: Revenue of $4.7M in FY 2025 and a reported net margin of 68% show that some reported earnings activity exists despite operating losses. With Fundamental Cash Engine at 1/20 (ROIC -32.8%, FCF yield —) and Institutional Whale Flow at 3/20, sustained execution supports upside toward the top of the $0.96 – $20,908.80 52-week range.
• 🐻 Primary Bear Case: A 1/20 Fundamental Cash Engine score, ROIC of -32.8%, FCF of -$11.1M against $0.8M of cash, and an Altman Z of 0.63 point to a high probability of financial distress. Investors must weigh current valuation against -60.0% operating margins and a 1.00 macro beta if sector demand softens.

— for upstream dependencies, downstream customers, or sector correlations. A prospective investor should monitor whether future filings identify concentrated dependencies, since the absence of mapped links means no second-order ripples can be evaluated from the supplied data.

• Key Question #1: What revenue-generating activities underlie the reported $4.7M of FY 2025 revenue, and what drove the swing from a $9.9M net income to a -$10.7M operating loss?
• Key Question #2: Why is the 52-week range so wide (from $0.96 to $20908.8), and does that reflect a corporate action, a data error, or extreme price volatility?
• Key Question #3: What debt obligations exist, given the Debt field is N/A in every reported period while Debt/Equity is cited as 0.5?